2C7S image
Deposition Date 2005-11-28
Release Date 2007-01-02
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2C7S
Keywords:
Title:
Crystal structure of human protein tyrosine phosphatase kappa at 1.95A resolution
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.21
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE KAPPA
Gene (Uniprot):PTPRK
Chain IDs:A
Chain Length:313
Number of Molecules:1
Biological Source:HOMO SAPIENS
Ligand Molecules
Primary Citation
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.
Protein Sci. 15 1500 1505 (2006)
PMID: 16672235 DOI: 10.1110/ps.062128706

Abstact

The receptor-type protein tyrosine phosphatases (RPTPs) are integral membrane proteins composed of extracellular adhesion molecule-like domains, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain consists of tandem PTP domains, of which the D1 domain is enzymatically active. RPTPkappa is a member of the R2A/IIb subfamily of RPTPs along with RPTPmu, RPTPrho, and RPTPlambda. Here, we have determined the crystal structure of catalytically active, monomeric D1 domain of RPTPkappa at 1.9 A. Structural comparison with other PTP family members indicates an overall classical PTP architecture of twisted mixed beta-sheets flanked by alpha-helices, in which the catalytically important WPD loop is in an unhindered open conformation. Though the residues forming the dimeric interface in the RPTPmu structure are all conserved, they are not involved in the protein-protein interaction in RPTPkappa. The N-terminal beta-strand, formed by betax association with betay, is conserved only in RPTPs but not in cytosolic PTPs, and this feature is conserved in the RPTPkappa structure forming a beta-strand. Analytical ultracentrifugation studies show that the presence of reducing agents and higher ionic strength are necessary to maintain RPTPkappa as a monomer. In this family the crystal structure of catalytically active RPTPmu D1 was solved as a dimer, but the dimerization was proposed to be a consequence of crystallization since the protein was monomeric in solution. In agreement, we show that RPTPkappa is monomeric in solution and crystal structure.

Legend

Protein

Chemical

Disease

Primary Citation of related structures